GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (CHIX:XLSz) » Definitions » Ending Cash Position

Xlife Sciences AG (CHIX:XLSZ) Ending Cash Position : CHF0.10 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Xlife Sciences AG Ending Cash Position?

Xlife Sciences AG's Ending Cash Position for the quarter that ended in Jun. 2024 was CHF0.10 Mil.

Xlife Sciences AG's quarterly Ending Cash Position declined from Jun. 2023 (CHF0.51 Mil) to Dec. 2023 (CHF0.22 Mil) and declined from Dec. 2023 (CHF0.22 Mil) to Jun. 2024 (CHF0.10 Mil).

Xlife Sciences AG's annual Ending Cash Position declined from Dec. 2021 (CHF1.96 Mil) to Dec. 2022 (CHF0.22 Mil) and declined from Dec. 2022 (CHF0.22 Mil) to Dec. 2023 (CHF0.22 Mil).

Xlife Sciences AG Ending Cash Position Historical Data

The historical data trend for Xlife Sciences AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG Ending Cash Position Chart

Xlife Sciences AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 2.54 4.70 1.96 0.22 0.22

Xlife Sciences AG Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 0.22 0.51 0.22 0.10

Xlife Sciences AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Xlife Sciences AG's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.221+-0.0020000000000001
=0.22

Xlife Sciences AG's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.219+-0.119
=0.10

Xlife Sciences AG Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (CHIX:XLSz) » Definitions » Ending Cash Position
Comparable Companies
XSWX:MOLN XSWX:NWRN XSWX:SANN XSWX:IDIA XSWX:BIOV XSWX:RLF XSWX:EVE XSWX:ADXN XSWX:BSLN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT
Traded in Other Exchanges
XLS:Switzerland
Address
Talacker 35, Zurich, CHE, 8001
Website
https://www.xlifesciences.ch
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.

Xlife Sciences AG Headlines

No Headlines